Can you provide the last earnings date for KNIGHT THERAPEUTICS INC?
KNIGHT THERAPEUTICS INC (GUD.CA) last reported earnings on 3/19/2026.
KNIGHT THERAPEUTICS INC (GUD.CA) Earnings History & Surprises
TSX:GUD • CA4990531069
Current stock price
7.65 CAD
+0.12 (+1.59%)
Last:
GUD.CA Earnings overview
Past quarterly earnings results for KNIGHT THERAPEUTICS INC (GUD.CA), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 6, 2026
- Period
- Q1 / 2026
- EPS Estimate
- CA$0.03
- Revenue Estimate
- 113.62M
Last Reported
Most Recent- Release Date
- Mar 19, 2026
- Period
- Q4 / 2025
- EPS Reported
- CA$0.09
- EPS Surprise
- 1,288.12%
- Revenue Surprise
- 12.31%
Beat Rate
Last 8 Quarters 69%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in CAD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 0.09 | -0.01 | 1,288.12% | -18.18% | 133.106M | 118.52M | 12.31% | 37.42% |
| Q3 2025 | -0.02 | 0.00 | -692.08% | - | 121.548M | 108.05M | 12.49% | 31.74% |
| Q2 2025 | -0.13 | 0.02 | -815.07% | -550.00% | 107.358M | 96.668M | 11.06% | 12.33% |
| Q1 2025 | 0.02 | 0.00 | 365.93% | 150.00% | 88.076M | 87.311M | 0.88% | 2.66% |
| Q4 2024 | 0.11 | 0.02 | 461.40% | 147.83% | 96.864M | 88.804M | 9.08% | 30.55% |
| Q3 2024 | 0.00 | 0.02 | -100.00% | -100.00% | 92.263M | 89.967M | 2.55% | 13.21% |
| Q2 2024 | -0.02 | 0.02 | -199.01% | -200.00% | 95.573M | 88.942M | 7.46% | 6.30% |
| Q1 2024 | -0.04 | 0.01 | -693.76% | - | 85.795M | 81.042M | 5.86% | 3.87% |
| Q4 2023 | -0.23 | -0.02 | -1,165.13% | -76.92% | 74.197M | 79.486M | -6.65% | -9.13% |
| Q3 2023 | 0.09 | -0.04 | 305.65% | 800.00% | 81.5M | 74.248M | 9.77% | 12.75% |
| Q2 2023 | 0.02 | -0.01 | 258.42% | - | 89.905M | 81.534M | 10.27% | 18.58% |
| Q1 2023 | -0.04 | -0.06 | 37.46% | 75.00% | 82.597M | 74.814M | 10.40% | 29.45% |
| Q4 2022 | -0.13 | -0.08 | -54.46% | -85.71% | 81.655M | 61.613M | 32.53% | 40.12% |
| Q3 2022 | 0.01 | -0.05 | 122.00% | 114.29% | 72.281M | 63.537M | 13.76% | -1.44% |
| Q2 2022 | 0.02 | -0.02 | 190.01% | -91.30% | 75.82M | 66.119M | 14.67% | 15.23% |
| Q1 2022 | -0.16 | -0.04 | -296.04% | -633.33% | 63.807M | 56.952M | 12.04% | 38.50% |
| Q4 2021 | -0.07 | 0.00 | -4,050.12% | -211.11% | 58.273M | 62.427M | -6.65% | 5.59% |
| Q3 2021 | -0.07 | 0.02 | -515.76% | -150.00% | 73.34M | 59.308M | 23.66% | 62.11% |
| Q2 2021 | 0.23 | -0.07 | 410.55% | 76.92% | 65.796M | 50.798M | 29.52% | 23.56% |
| Q1 2021 | 0.03 | -0.02 | 248.51% | 400.00% | 46.07M | 49.187M | -6.34% | 0.50% |
| Q4 2020 | 0.06 | 0.01 | 773.62% | - | 55.19M | 49.6M | 11.27% | - |
| Q3 2020 | 0.14 | 0.00 | 3,365.35% | - | 45.24M | 51.966M | -12.94% | - |
| Q2 2020 | 0.13 | -0.03 | 614.85% | - | 53.25M | 51.263M | 3.88% | - |
| Q1 2020 | -0.01 | -0.06 | 82.32% | - | 45.84M | 55.088M | -16.79% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
2
Average EPS beat (4)
36.72%
Max EPS beat (4)
1,288.12%
Min EPS beat (4)
-815.07%
Revenue beat statistics
Revenue beat (4)
4
Average Revenue beat (4)
9.18%
Max Revenue beat (4)
12.49%
Min Revenue beat (4)
0.88%
Analysis
In the last 4 quarters, GUD.CA has beaten EPS estimates in 2 out of 4 releases
GUD.CA has consistently beaten revenue estimates in all past 4 earnings releases
In the last 4 quarters, GUD.CA has beaten the EPS estimates by 36.7% on average.
In the last 4 quarters, GUD.CA has beaten the revenue estimates by 9.2% on average.
Related analysis
KNIGHT THERAPEUTICS INC / GUD.CA Earnings FAQ
Did GUD stock beat earnings estimates in the most recent quarter?
KNIGHT THERAPEUTICS INC (GUD.CA) beat EPS estimates and beat revenue estimates in the most recent quarter.
How often does KNIGHT THERAPEUTICS INC (GUD.CA) beat earnings estimates?
In the last 4 quarters, KNIGHT THERAPEUTICS INC (GUD.CA) has beaten EPS estimates in 2 out of 4 releases.